These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12691146)

  • 1. High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.
    Plasschaert SL; Vellenga E; de Bont ES; van der Kolk DM; Veerman AJ; Sluiter WJ; Daenen SM; de Vries EG; Kamps WA
    Leuk Lymphoma; 2003 Jan; 44(1):85-95. PubMed ID: 12691146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia.
    van der Kolk DM; de Vries EG; Noordhoek L; van den Berg E; van der Pol MA; Müller M; Vellenga E
    Leukemia; 2001 Oct; 15(10):1544-53. PubMed ID: 11587212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.
    Plasschaert SL; de Bont ES; Boezen M; vander Kolk DM; Daenen SM; Faber KN; Kamps WA; de Vries EG; Vellenga E
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8661-8. PubMed ID: 16361551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.
    Damiani D; Michelutti A; Michieli M; Masolini P; Stocchi R; Geromin A; Ermacora A; Russo D; Fanin R; Baccarani M
    Br J Haematol; 2002 Mar; 116(3):519-27. PubMed ID: 11849207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.
    Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A
    Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.
    Ogretmen B; Barredo JC; Safa AR
    J Pediatr Hematol Oncol; 2000; 22(1):45-9. PubMed ID: 10695821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study.
    Dhooge C; De Moerloose B; Laureys G; Ferster A; De Bacquer D; Philippe J; Leroy J; Benoit Y
    Leuk Lymphoma; 2002 Feb; 43(2):309-14. PubMed ID: 11999562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study.
    Dhooge C; De Moerloose B; Laureys G; Kint J; Ferster A; De Bacquer D; Philippe J; Benoit Y
    Br J Haematol; 1999 Jun; 105(3):676-83. PubMed ID: 10354131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study.
    Dhooge C; De Moerloose B
    Adv Exp Med Biol; 1999; 457():11-9. PubMed ID: 10500775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
    Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
    Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia.
    Sauerbrey A; Voigt A; Wittig S; Häfer R; Zintl F
    Leuk Lymphoma; 2002 Apr; 43(4):875-9. PubMed ID: 12153178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
    Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
    J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of MDR1, MRP1, GSTpi and GSTmu mRNA expression in acute lymphoblastic leukemia in Indian patients.
    Gurbuxani S; Singh Arya L; Raina V; Sazawal S; Khattar A; Magrath I; Marie J; Bhargava M
    Cancer Lett; 2001 Jun; 167(1):73-83. PubMed ID: 11323101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression.
    Legrand O; Perrot JY; Simonin G; Baudard M; Cadiou M; Blanc C; Ramond S; Viguié F; Marie JP; Zittoun R
    Br J Haematol; 1998 Jan; 100(1):147-55. PubMed ID: 9450804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.
    Olson DP; Taylor BJ; La M; Sather H; Reaman GH; Ivy SP
    Leuk Lymphoma; 2005 May; 46(5):681-91. PubMed ID: 16019505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia.
    Shman TV; Savitskii VP; Potapnev MP; Aleinikova OV
    Bull Exp Biol Med; 2006 Jun; 141(6):727-30. PubMed ID: 17364061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.